Episode 96: A chemist breaks bad, the latest on the coronavirus, and pharma’s slow Bern
Is it wise to lie to the feds? Is pharma taking Sen. Bernie Sanders seriously? And what constitutes a "public health emergency of international concern?"
30 Jan 202026min
Episode 95: The latest on the China virus, Sarepta's ongoing FDA saga, and biotech at Davos
Are we dealing with a SARS redux? Has the FDA lost its teeth? And what do billionaires talk to each other about?
23 Jan 202022min
Episode 94: EQRx's Alexis Borisy, Stephen Buck on his website for cancer patients, and a JPM recap
Why weren't there any big deals announced this week? What does the word "equivalar" mean? And why is information about prognosis so hard to find?
16 Jan 202023min
Episode 93: Josiah Zayner on getting canceled, good news in cancer, an Ebola vaccine saga
Does pharma deserve more credit? Will history forgive He Jiankui? And how does a laboratory eureka become a lifesaving vaccine?
9 Jan 202026min
Episode 92: The decade in breakthroughs, the year in bad CEOs, and the viruses that cure disease
Which drug defined the decade? Who's the worst CEO in biopharma? And how does gene therapy actually work?
19 Des 201924min
Episode 91: CAR-T's future, an alarming cancer trend & Chris Garabedian on Sarepta's FDA legacy
Has CAR-T lost its luster? Why is colorectal cancer on the rise? And did the FDA forever change in 2016?
12 Des 201925min
Episode 90: Biogen's big reveal, hot takes on Alzheimer's, & the science of one-eyed sheep
How do you know if a "positive" study is positive? And how did one-eyed sheep lead to a drug for certain cancers?
5 Des 201924min
Episode 89: Warren's awkward home front, a dwarfism drug, and the sound of STAT Summit
Can Sen. Elizabeth Warren ever go home again? Is it ethical to make little people taller? And when will AI come up with a new drug?
22 Nov 201924min
